Entering text into the input field will update the search result below

Why Isn't Everything So Obvious With Alibaba's Future

Nathan Aisenstadt profile picture
Nathan Aisenstadt
3.44K Followers

Summary

  • Alibaba's revenue for the first three months of 2023 was $30.32 billion, down 15.6% from the previous quarter and 5.8% from the fourth quarter of fiscal 2022.
  • At the end of March 2023, Alibaba's total debt was about $23.5 billion, down about $4.2 billion from 2021.
  • We initiate our coverage of Alibaba with a "hold" rating for the next 12 months.
  • According to the National Bureau of Statistics of China, the total retail sales of consumer goods amounted to 3,491 billion yuan in April 2023, down 7.8% from the previous month and reaching the lowest level in the past ten months.
  • Also, we believe that the US presidential election, scheduled for November 5, 2024, will lead to stricter rhetoric from US politicians, who will likely choose to contain China as one of the main topics in their election campaigns.

Yahoo Takes 40 pct Stake in China"s Alibaba

Guang Niu

The Alibaba Group (NYSE:BABA) is a global technology conglomerate founded in the late 20th century by Jack Ma and eventually nicknamed the "Chinese Amazon." However, the business of one of the world leaders in e-commerce and cloud computing is more

Created by author

Created by author

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on the National Bureau of Statistics of China

Author's elaboration, based on the National Bureau of Statistics of China

Author's elaboration, based on quarterly securities reports

Author's elaboration, based on quarterly securities reports

Author's elaboration, based on Seeking Alpha and quarterly securities reports

Author's elaboration, based on Seeking Alpha and quarterly securities reports

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

Author's elaboration, based on Seeking Alpha

This article was written by

Nathan Aisenstadt profile picture
3.44K Followers
I am an independent research analyst focused on finding undervalued assets with above-average growth rates and developments that can dramatically improve the company's financial position. When investing, I use medium-term and long-term trading strategies that take into account psychological and behavioral variables and are able to mitigate the risks associated with macroeconomic and geopolitical instability.The main sectors of analysis are industrials, materials, crypto, and healthcare.When analyzing assets in the healthcare sector, in addition to examining their financial position, I delve into the safety and efficacy data of the company's product candidates from preclinical and clinical studies, allowing me to evaluate their commercial prospects. While the education received at the Hebrew University of Jerusalem contributes to a comprehensive and detailed analysis of biotechnological and physicochemical processes used in the production of goods in the agricultural, oil and gas, and chemical industries. As a result, it allows me to find the most promising assets in a rapidly changing market and publish meaningful articles on Seeking Alpha.My e-mail for any questions and suggestions: aisenathan@gmail.com

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sell securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.